U.S., Feb. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07423975) titled 'Advancing Reperfusion Therapy for Ischemic Stroke: Safety and Efficacy of Anakinra for Futile Reperfusion Following Endovascular Treatment in Patients With Acute Ischemic Stroke' on Feb. 14.
Brief Summary: The investigators initiated a multicenter, prospective, randomized, open label, blinded-endpoint (PROBE) controlled trial to explore the safety and efficacy of different dose of Anakinra compared to standard medical care for patients with acute ischemic stroke who have achieved successful recanalization after endovascular thrombectomy.
Study Start Date: March 01
Study Type: INTERVENTIONAL
Condition:
Stroke Acute
Endovascular T...